Health Care

Ignoring medical bills could leave your credit in more pain than you went to the doctor for.

Fewer health-care financing options populate the market since the recession. Compare the terms and conditions of the top medical credit cards and loans before you apply.

Insurance companies and government agencies are increasingly using plastic and virtual credit cards to pay doctors. But practices can request other payment methods that carry lower fees.

GE Capital's CareCredit card pays dozens of professional societies to help market its high-rate health care credit card, raising questions that could cloud the doctor-patient relationship.

Should you put the bill on your favorite rewards credit card? Here are some things to consider before pulling out your card.

A study by a pair of University of Michigan sociologists finds people who are ill and don't seek treatment because of the cost are more likely to have credit card debt than other forms of debt.

Insurance is a bet, so knowing your genetic destiny changes the odds.

With a new CEO and financial backing from North Castle, boutique fitness brand, Barry’s Bootcamp is looking to grow in new territories.

Johnson & Johnson signed off on a $4 billion bid from private-equity giant Carlyle Group to acquire the blue-chip company’s blood-testing business.

Johnson & Johnson received a $4.15 billion offer to sell its slow-growing ortho-clinical diagnostics business to private-equity firm Carlyle Group. 

Johnson & Johnson is reportedly nearing a deal to sell its ortho clinical diagnostics division to Carlyle for about $4 billion.

Marking the private-equity giant’s ever investment in Japan, KKR unveiled a deal to acquire Panasonic Healthcare from Panasonic for $1.7 billion.

While two potential drugs to treatment Alzheimer's show progress, it is not fast enough for the 5.3 million patients suffering from the disease. 

Merck & Co. says its board approved the repurchase of up to $10 billion more of its stock.

Pfizer will buy back $5 billion of its stock under an agreement with Goldman Sachs.

Gilead Sciences Inc. said Tuesday that sales of its newest hepatitis C drug, Harvoni, totaled $2.11 billion in the fourth quarter.

Drugmaker Pfizer says it approved the repurchase of $11 billion in company stock.

The world's largest health insurer raised its dividend by 34% on Wednesday and renewed its buyback program.

A blockbuster year for deal making: 2014 is on track to see the greatest volume of M&A transactions on record thanks to 7,823 year-to-date proposals.